Sermorelin access requires medical evaluation and provider oversight.

Sermorelin is a growth hormone-releasing hormone analog with a generally favorable safety profile in clinical trials, though injection site reactions and transient hormonal effects occur. Safety depends on individual health status, concurrent medications, and provider oversight.

Ipamorelin and sermorelin are secretagogues that stimulate growth hormone release through different mechanisms. Ipamorelin acts selectively on ghrelin receptors, while sermorelin mimics GHRH.

Sermorelin outcomes vary significantly between individuals due to age, baseline growth hormone levels, and genetic factors. Understanding expected timelines, biomarker context, and personalized assessment helps patients set realistic expectations and work effectively with healthcare providers.

Sermorelin is a synthetic peptide that stimulates the pituitary gland to release growth hormone, used clinically for age-related decline and specific medical conditions.

Sermorelin is a growth hormone-releasing hormone analog used to stimulate endogenous GH production. Common side effects include injection site reactions, flushing, and headache.

Sermorelin shows measurable effects on growth hormone secretion in controlled studies, but real-world efficacy varies significantly based on age, baseline hormone levels, and individual physiology.

Sermorelin dosage typically ranges from 0.2–0.5 mg subcutaneously, with protocols varying by clinical indication and individual response. Biomarker assessment and baseline growth hormone levels can help providers tailor initial dosing and titration strategies.

The Longevity-Aging pathway in the Precision Peptide Genetic Test delivers 17 insights organized across five functional clusters — antioxidant defense, NAD+ homeostasis, methylation, longevity transcription factors, and structural aging biology. Part of 14 pathways, 49 peptides, and 150+ genetic insights, these 17 variants map biological aging as a connected system, not a list of isolated risk genes.

Antioxidant capacity is not a single number — it is the combined genetic output of five overlapping enzyme systems, each with its own variant layer. The Precision Peptide Genetic Test maps SOD2, GPX1, GCLC, NFE2L2, FOXO3, and more across 14 pathways, 49 peptides, and 150+ genetic insights, revealing the genetic architecture your antioxidant biology is built on.

Yes — FOXO3 is one of the most replicated longevity genes in human genetics, and rs2802292 is the variant that explains why. The Precision Peptide Genetic Test analyzes FOXO3 alongside 14 pathways, 49 peptides, and 150+ genetic insights, revealing how your transcription factor genetics shapes oxidative stress resistance, DNA repair, and cellular lifespan.

Mitochondria generate the energy that powers every biological process — and mitochondrial decline is one of the most upstream drivers of aging. NRF2, KLOTHO, SOD2, SIRT1, FOXO3, and MTHFR all converge on mitochondrial biology. The Precision Peptide Genetic Test analyzes 17 Longevity & Aging insights spanning 14 pathways, 49 peptides, and 150+ genetic insights.

FOXO3 is the most replicated longevity gene in science — variants are consistently associated with exceptional lifespan across independent centenarian cohorts in Japan, Italy, and the United States. The Precision Peptide Genetic Test analyzes FOXO3 as part of 17 Longevity & Aging insights within a panel spanning 14 pathways, 49 peptides, and 150+ genetic insights.

Peptide protocols fail many people not because the science is wrong, but because they're built for population averages. FTO, FOXO3, ACTN3, SHBG, and COMT variants mean weight management, longevity, muscle, and hormone biology works differently in everyone. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150+ genetic insights to reveal exactly where your biology diverges.

The Precision Peptide Genetic Test analyzes 17 longevity and aging genetic insights — FOXO3, SOD2, APOE, SIRT1, and TERT among them — within a panel of 14 pathways, 49 peptides, and 150+ genetic insights. This pillar guide breaks down each longevity gene, what it signals about healthspan, and why your DNA is the highest-leverage variable in any aging strategy.

The Precision Peptide Genetic Test analyzes your genetic response to the pathways targeted by 49 unique compounds across five protocol families — GLP-1, growth hormone, androgens, estrogens, and vascular modulators. This post breaks down how each protocol family maps to genetic pathways, what the 49-peptide panel covers, and what your results reveal.

Genetic testing reveals tendencies, not outcomes — a FOXO3 variant doesn't predict lifespan, a slow-COMT variant doesn't diagnose any condition, an ACTN3 XX genotype doesn't cap muscle growth. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, and 150+ genetic insights. Understanding what DNA can and cannot tell you is the difference between informed and overconfident.

Your Precision Peptide Genetic Test report delivers 150+ insights across 14 pathways — FOXO3 for longevity, ACTN3 for muscle, COMT for methylation, and more. This guide walks through how to read pathway scores, interpret gene variants, and synthesize findings into the informed conversation every peptide protocol decision should start with.

Before committing to a peptide protocol, genetic testing reveals how your body will actually respond across GLP-1 signaling, growth hormone axis, estrogen clearance, and sexual response pathways. The Precision Peptide Genetic Test maps 14 pathways, 49 peptides, and 150+ genetic insights. Test first. Invest second. That sequence is the entire premise of precision peptide decisions.

The precision health stack is a 4-layer system: genetic testing as the foundation, blood work for state data, supplements and lifestyle for baseline support, and protocols as the intervention layer. The Precision Peptide Genetic Test anchors the stack — analyzing 14 pathways, 49 peptides, and 150+ genetic insights that shape how every layer above performs.

Genetic peptide testing analyzes how your DNA shapes 14 biological pathways that peptide protocols target — from GLP-1 signaling to growth hormone axis to estrogen clearance. The PlexusDx Precision Peptide Genetic Test delivers 150+ insights across 49 unique peptides, turning peptide decisions from guesswork into evidence-based conversations with your healthcare provider.

The Precision Peptide Genetic Test processes raw DNA through Illumina Global Screening Array genotyping, CLIA-certified lab analysis, and AI-driven pathway interpretation — transforming 57 SNPs across 48 genes into 150+ actionable insights spanning 14 pathways and 49 peptides. This post explains how that pipeline works end to end, from saliva sample to personalized genetic report.

The PlexusDx Precision Peptide Genetic Test analyzes 17 longevity-aging genetic insights across five peptide pathways — Epitalon, FOXO4-DRI, Glutathione, Humanin, and Vilon — covering 15 SNPs across 14 genes including FOXO3, TERT, SIRT1, GPX1, and PPARGC1A. This article explains what each insight reveals and why peptide-specific longevity testing is a distinct category of genetic analysis.